82
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Matrix metalloproteinase-2 C-735T and its interaction with matrix metalloproteinase-7 A-181G polymorphism are associated with the risk of preeclampsia: influence on total antioxidant capacity and blood pressure

, , , , , & show all
Pages 327-332 | Received 11 Nov 2016, Accepted 07 Jun 2017, Published online: 10 Oct 2017

References

  • Ahmadi R, Rahimi Z, Vaisi-Raygani A, Kiani A, Jalilian N, Rahimi Z. 2012. Apolipoprotein E genotypes, lipid peroxidation, and antioxidant status among mild and severe preeclamptic women from western Iran: protective role of apolipoprotein ɛ2 allele in severe preeclampsia. Hypertension in Pregnancy 31:405–418.
  • Ding J, Huang F, Wu G, Han T, Xu F, Weng D, et al. 2015. MiR-519d-3p suppresses invasion and migration of trophoblast cells via targeting MMP-2. PLoS One 10: e0120321.
  • Galewska Z, Bankowski E, Romanowicz L, Jaworski S. 2003. Pre-eclampsia (EPH-gestosis)-induced decrease of MMPs contained in the umbilical cord artery. Clinica Chimica Acta 335:109–115.
  • Gellersen B, Reimann K, Samalecos A, Aupers S, Bamberger AM. 2010. Invasiveness of human endometrial stromal cells is promoted by decidualization and by trophoblast-derived signals. Human Reproduction (Oxford, England) 25:862–873.
  • He P, Shao D, Ye M, Zhang G. 2015. Analysis of gene expression identifies candidate markers and pathways in pre-eclampsia. Journal of Obstetrics and Gynaecology 35:578–584.
  • Jafari Y, Rahimi Z, Vaisi-Raygani A, Rezaei M. 2011. Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients. Molecular and Cellular Biochemistry 353:23–34.
  • Li W, Mata KM, Mazzuca MQ, Khalil RA. 2014. Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy. Biochemical Pharmacology 89:370–385.
  • Malek-Khosravi S, Rahimi Z, Rahimi Z, Jalilvand F, Parsian A. 2012. Thrombophilic mutations and susceptibility to preeclampsia in Western Iran. Journal of Thrombosis and Thrombolysis 33:109–115.
  • Merchant SJ, Davidge ST. 2004. The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and pre-eclampsia. BJOG 111:931–939.
  • Nasrollahi S, Hoseini Panah SM, Tavilani H, Tavasoli S, Naderan M, Shoar S. 2015. Antioxidant status and serum levels of selectins in pre-eclampsia. Journal of Obstetrics and Gynaecology 35:16–18.
  • Palei AC, Sandrim VC, Cavalli RC, Tanus-Santos JE. 2008. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension. Clinical Biochemistry 41:875–880.
  • Palei AC, Sandrim VC, Amaral LM, Machado JS, Cavalli RC, Lacchini R, et al. 2012. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy. Basic and Clinical Pharmacology and Toxicology 111:262–267.
  • Rahimi Z, Vaisi-Raygani A, Rahimi Z, Parsian A. 2012. Concomitant presence of endothelial nitric oxide 894T and angiotensin II-converting enzyme D alleles are associated with diabetic nephropathy in a Kurdish population from Western Iran. Nephrology 17:175–181.
  • Rahimi Z, Ahmadi R, Vaisi-Raygani A, Rahimi Z, Bahrehmand F, Parsian A. 2013. Butyrylcholinesterase (BChE) activity is associated with the risk of preeclampsia: influence on lipid and lipoprotein metabolism and oxidative stress. Journal of Maternal-Fetal and Neonatal Medicine 26:1590–1594.
  • Rahimi Z, Malek-Khosravi S, Rahimi Z, Jalilvand F, Parsian A. 2013. MTHFR C677T and eNOS G894T variants in preeclamptic women: contribution to lipid peroxidation and oxidative stress. Clinical Biochemistry 46:143–147.
  • Rahimi Z, Rahimi Z, Shahsavandi MO, Bidoki K, Rezaei M. 2013. MMP-9 (-1562 C:T) polymorphism as a biomarker of susceptibility to severe pre-eclampsia. Biomarkers in Medicine 7:93–98.
  • Rahimi Z, Rahimi Z, Aghaei A, Vaisi-Raygani A. 2014. AT2R -1332 G:A polymorphism and its interaction with AT1R 1166 A:C, ACE I/D and MMP-9 -1562 C:T polymorphisms: risk factors for susceptibility to preeclampsia. Gene 538:176–181.
  • Rahimi Z, Kazemian L, Malek-Khosravi S, Najafi F, Rahimi Z. 2015. Matrix metalloproteinase-7 A-181G and its interaction with matrix metalloproteinase-9 C-1562T polymorphism in preeclamptic patients: association with malondialdehyde level and severe preeclampsia. Archives of Gynecology and Obstetrics 291:45–51.
  • Rahimi Z, Abdan Z, Rahimi Z, Razazian N, Shiri H, Vaisi-Raygani A, et al. 2016. Functional promoter polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and their synergism with MMP-7 A-181G in multiple sclerosis. Immunological Investigations 45:543–552.
  • Shahvaisizadeh F, Movafagh A, Omrani MD, Vaisi-Raygani A, Rahimi Z, Rahimi Z. 2014. Synergistic effects of angiotensinogen -217 G→A and T704C (M235T) variants on the risk of severe preeclampsia. Journal of the Renin-Angiotensin-Aldosterone System 15:156–161.
  • Vincent ZL, Mitchell MD, Ponnampalam AP. 2015. Regulation of MT1-MMP/MMP-2/TIMP-2 axis in human placenta. Journal of Inflammation Research 8:193–200.
  • Yari K, Rahimi Z, Moradi MT, Rahimi Z. 2014. The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer. Asian Pacific Journal of Cancer Prevention 15:6199–6203.
  • Yari K, Rahimi Z, Payandeh M, Rahimi Z. 2015. MMP-7 A-181G polymorphism in breast cancer patients from Western Iran. Breast Care (Basel, Switzerland) 10:398–402.
  • Yin Z, Sada AA, Reslan OM, Narula N, Khalil RA. 2012. Increased MMPs expression and decreased contraction in the rat myometrium during pregnancy and in response to prolonged stretch and sex hormones. American Journal of Physiology. Endocrinology and Metabolism 303:E55–E70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.